Freeze-drying of squalenoylated nucleoside analogue nanoparticles

International Journal of Pharmaceutics

Volumn 381, Issue 2, 2009, Pages 140-145

  Bildstein, L ^a   Hillaireau, H ^a   Desmaele D ^a   Lepetre Mouelhi S ^a   Dubernet, C ^a   Couvreur, P ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Freeze drying; Nanoparticles; Nucleoside analogues; Squalene; Stability

Indexed keywords

DIDANOSINE; GEMCITABINE; NANOPARTICLE; NUCLEOSIDE ANALOG; SQUALENE; TREHALOSE; ZALCITABINE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; COVALENT BOND; CRYOPROTECTION; CYTOTOXICITY; DRUG STABILITY; DRUG STORAGE; FREEZE DRYING; IN VITRO STUDY; LIGHT SCATTERING; NONHUMAN; PRIORITY JOURNAL;

EID: 70349296818     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.04.002     Document Type: Article

References (18)

1. Abdelwahed W., Degobert G., Stainmesse S., and Fessi H. Freeze-drying of nanoparticles: formulation, process and storage considerations. Adv. Drug Deliv. Rev. 58 (2006) 1688-1713
2. Bekkara-Aounallah, F., Gref, R., Othman, M., Reddy, L.H., Pili, B., Allain, V., Bourgaux, C., Hillaireau, H., Lepêtre-Mouelhi, S., Desmaële, D., Nicolas, J., Chafi, N., Couvreur, P., Submitted for publication. Novel PEGylated nanoassemblies made of self-assembled squalenoyl nucleoside analogues. Adv. Funct. Mater.
3. Bergman A.M., Pinedo H.M., and Peters G.J. Determinants of resistance to 2′,2′-difluorodeoxycytidine (gemcitabine). Drug Resist. Updat. 5 (2002) 19-33
4. Cass C.E. Nucleoside transport. In: Georgopapadakou N.H. (Ed). Drug Transport in Antimicrobial and Anticancer Chemotherapy (1995), Marcel Dekker, New York 403
5. Couvreur P., Reddy L.H., Mangenot S., Poupaert J.H., Desmaële D., Lepêtre-Mouelhi S., Pili B., Bourgaux C., Amenitsch H., and Ollivon M. Discovery of new hexagonal supramolecular nanostructures formed by squalenoylation of an anticancer nucleoside analogue. Small 4 (2008) 247-253
6. Couvreur P., Stella B., Reddy L.H., Hillaireau H., Dubernet C., Desmaële D., Lepêtre-Mouelhi S., Rocco F., Dereuddre-Bosquet N., Clayette P., Rosilio V., Marsaud V., Renoir J.M., and Cattel L. Squalenoyl nanomedicines as potential therapeutics. Nano Lett. 6 (2006) 2544-2548
7. Crowe J.H., Crowe L.M., Oliver A.E., Tsvetkova N., Wolkers W., and Tablin F. The trehalose myth revisited: introduction to a symposium on stabilization of cells in the dry state. Cryobiology 43 (2001) 89-105
8. Crowe L.M., Reid D.S., and Crowe J.H. Is trehalose special for preserving dey biomaterials?. Biophys. J. 71 (1996) 2087-2093
9. Dumontet C., Fabianowska-Majewska K., Mantincic D., Callet Bauchu E., Tigaud I., Gandhi V., Lepoivre M., Peters G.J., Rolland M.O., Wyczechowska D., Fang X., Gazzo S., Voorn D.A., Vanier-Viornery A., and MacKey J. Common resistance mechanisms to deoxynucleoside analogues in variants of the human erythroleukaemic line K562. Br. J. Haematol. 106 (1999) 78-85
10. Khoury H., Deroussent A., Reddy L.H., Couvreur P., Vassal G., and Paci A. Simultaneous determination of gemcitabine and gemcitabine-squalene by liquid chromatography-tandem mass spectrometry in human plasma. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 858 (2007) 71-78
11. Lenne T., Bryant G., Garvey C.J., Keiderling U., and Koster K.L. Location of sugars in multilamellar membranes at low hydration. Physica B 385-386 (2006) 862-864 part 2
12. Liu Q., Schmidt R.K., Teo B., Karplus P.A., and Brady J.W. Molecular dynamics study of the hydration of α,α-trehalose. J. Am. Chem. Soc. 119 (1997) 7851-7862
13. Mackey J.R., Mani R.S., Selner M., Mowles D., Young J.D., Belt J.A., Crawford C.R., and Cass C.E. Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines. Cancer Res. 58 (1998) 4349-4357
14. Reddy L.H., Khoury H., Paci A., Deroussent A., Ferreira H., Dubernet C., Declèves X., Besnard M., Chacun H., Lepêtre-Mouelhi S., Desmaële D., Rousseau B., Laugier C., Cintrat J.C., Vassal G., and Couvreur P. Squalenoylation favorably modifies the in vivo pharmacokinetics and biodistribution of gemcitabine in mice. Drug Metab. Dispos. 36 (2008) 1570-1577
15. Reddy L.H., Marque P.E., Dubernet C., Lepetre-Mouelhi S., Desmaële D., and Couvreur P. Preclinical toxicology (subacute and acute) and efficacy of a new squalenoyl gemcitabine anticancer nanomedicine. J. Pharmacol. Exp. Ther. 325 (2008) 484-490
16. Ruiz van Haperen V.W., Veerman G., Eriksson S., Boven E., Stegmann A.P., Hermsen M., Vermorken J.B., Pinedo H.M., and Peters G.J. Development and molecular characterization of a 2′,2′-difluorodeoxycytidine-resistant variant of the human ovarian carcinoma cell line A2780. Cancer Res. 54 (1994) 4138-4143
17. Sum A.K., Faller R., and de Pablo J.J. Molecular simulation study of phospholipid bilayers and insights of the interactions with disaccharides. Biophys. J. 85 (2003) 2830-2844
18. van Winden E.C., Zhang W., and Crommelin D.J. Effect of freezing rate on the stability of liposomes during freeze-drying and rehydration. Pharm. Res. 14 (1997) 1151-1160